Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new ...

The investigational monoclonal antibody barzolvolimab significantly improved provocation test outcomes and reduced symptoms ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new ...

Findings from a post hoc analysis of the AREDS and AREDS2 studies were presented at the recent American Academy of ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new ...

HOUSTON -- Two-thirds of patients with PI3K -mutant brain metastases responded to the maximum tolerated dose (MTD) of the ...

In clinical trials, most participants taking semaglutide or tirzepatide (Mounjaro, Zepbound) to treat obesity lost an average ...

Looking at the prevalence of myopia grouped by age, 8-year-old and 17-year-old patients had the greatest increase compared ...

"It's a real regulatory dilemma here." -- Donald Kohn, MD, of the University of California Los Angeles, at an FDA advisory ...

HOUSTON -- Progression-free survival (PFS) in IDH -mutant low-grade glioma remained twice as high in adults who received ...

President-elect Donald Trump has chosen Marty Makary, MD, MPH, to run the FDA. Makary served as the editor-in-chief of ...

AI that only sees you in a red dress and assumes "red" defines you, healthcare AI may fixate on misleading patterns, giving ...